Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05728463
Other study ID # 2022-0533
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 6, 2023
Est. completion date February 6, 2025

Study information

Verified date February 2023
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Daren Liu, MD, PhD
Phone +86-15968179036
Email darenliu@zju.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Laparoscopic cholecystectomy has been accepted and is nowadays considered as the gold standard treatment of gallstones disease. Conventional laparoscopic cholecystectomy (CLC) was defined as three or four port surgery carried out with either French or American position. It reduced post-operative pain and shorten post-operative length of stay compared with open cholecystectomy in a great extent. Single-incision laparoscopic cholecystectomy (SILC) as a revolutionized surgery, the main reason for its widespread use being the following: less post-operative pain, faster recovery, better cosmetics and quicker return to full activities, all resulting in the improvement of post-operative quality of life. SILC uses the umbilicus as a natural orifice allowing easy access to peritoneal cavity, easy conversion to standard laparoscopy and its easy closure, has been widely introduced into the clinical practice for benign gallbladder diseases. SILC can easily hide the surgical scar inside the umbilicus, thus has better cosmetic effect. But the real clinical benefits for patients still remain a matter of debate. In the last 5 years, many studies on SILC have been published, trying to answer the question whether such a new approach is worthwhile or not and whether is safe and cost-effective.Based on the above controversy, we conduct a RCT comparing clinical and peri-operative outcomes, such as quality of life (QOL), of SILC and CLC with the intent to assess the actual indications of the single-incision approach.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date February 6, 2025
Est. primary completion date February 6, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Benign gallbladder disease Exclusion Criteria: - Combined with liver cirrhosis (Child grade B and above) - Upper abdominal surgical history; - Gallbladder gangrene perforation; - Changes in surgical plan (conversion to laparotomy,cholangiography, bile duct exploration, bile duct injury repair, abscess clearance, multivisceral resection.) - patients and their families do not agree with the treatment lost follow-up

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Laparoscopic cholecystectomy
Laparoscopic cholecystectomy is defined as total or subtotal desection of the gallbladder laparoscopically.

Locations

Country Name City State
China 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China Hangzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of life (time to return to normal life) The quality of life of patients after operation was investigated by a unified SF-36 questionnaire. 2 years
Secondary Cosmetic result Evaluation of postoperative incisional scarring using the Vancouver Scar Scale 2 years
Secondary Grade II or above incidence of complications 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT06074679 - Clinical Study of Single Incision Laparoscopic Cholecystectomy in the Treatment of Patients With Acute Cholecystitis N/A
Completed NCT02575443 - Neuromuscular Block and Anesthetic Depth Monitoring N/A
Completed NCT04745273 - Interaction Between Tramadol and Ondansetron Phase 4
Not yet recruiting NCT03018964 - Solo Single Incision Laparoscopic Cholecystectomy N/A
Completed NCT01523886 - The Muscle Relaxation-study Phase 4
Completed NCT05214157 - Optimizing Pain Management Following Laparoscopic Cholecystectomy RCT N/A
Completed NCT03586791 - Comparison of Pupillometry-guided Anesthesia With Surgical Pleth Index Guided Anesthesia N/A
Completed NCT03794271 - Effect of Pupilometer Guided Analgesia on Postoperative Pain N/A
Completed NCT02185716 - Transversus Abdominis Plane Block (TAP) for Laparoscopic Cholecystectomy Surgery Phase 4
Not yet recruiting NCT06193837 - Prophylactic Antibiotic in Non-complicated Low Risk Lap Cholecystectomy (LC)
Completed NCT04254237 - Trocar Site Hernia After Laparoscopic Cholecystectomy, Supra Versus Infraumbilical Incision for Umbilical Trocar Entry N/A
Completed NCT00892879 - A Trial of Single Port Laparoscopic Cholecystectomy Versus Four Port Laparoscopic Cholecystectomy Phase 3
Completed NCT00848146 - NOTES-Assisted Laparoscopic Cholecystectomy Surgery N/A
Not yet recruiting NCT02978989 - Solo and Non-solo Approach for Laparoscopic Cholecystectomy N/A
Completed NCT05728073 - Does Subtotal Cholecystectomy Rate for Acute Cholecystitis Change With a Previous ERCP?
Completed NCT05532436 - The Effect of Breath Exercise on Patients' Post-Operative Anxiety Level, Sleep and Recovery Quality N/A
Completed NCT03241875 - Effects of Preoperative Gabapentin Versus Pregabalin on Shoulder Pain After Laparoscopic Cholecystectomy Phase 4
Completed NCT00288899 - Benefits of 'Repeat Back' Protocols Within A Computer-Based Informed Consent Program Phase 1
Completed NCT03258177 - Virtual Visits (Utilization of Virtual Care in Postoperative Patients to Improve the Patient Experience) N/A
Recruiting NCT01094379 - A Randomised Comparison Between Single Incision Laparoscopic Cholecystectomy and Standard Laparoscopic Cholecystectomy N/A